| |
| |
|
| Insider
Information: |
Gold Mitchell |
| Relationship: |
Executive Chairman and... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
457,263 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
457,263 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Dendreon Corp |
DNDN |
Director |
2013-01-03 |
457,263 |
2003-09-03 |
0 |
Premium* |
|
|
Alpine Immune Sciences Inc |
ALPN |
Executive Chairman and... |
2024-05-20 |
0 |
2024-05-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
140 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DNDN |
Dendreon Corp |
President & CEO |
• – – |
2012-04-21 |
4 |
D |
$10.35 |
$9,615 |
D/D |
(929) |
630,027 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-10-21 |
4 |
D |
$10.36 |
$13,271 |
D/D |
(1,281) |
222,277 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-04-14 |
4 |
AS |
$10.52 |
$105,200 |
D/D |
(10,000) |
250,039 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-05-13 |
4 |
AS |
$11.52 |
$115,169 |
D/D |
(10,000) |
230,039 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-05-12 |
4 |
AS |
$11.68 |
$116,842 |
D/D |
(10,000) |
240,039 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-02-02 |
4 |
AS |
$11.74 |
$117,381 |
D/D |
(10,000) |
290,039 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-02-01 |
4 |
AS |
$12.07 |
$128,665 |
D/D |
(10,000) |
300,039 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2020-12-31 |
4 |
D |
$12.60 |
$140,150 |
D/D |
(11,123) |
310,039 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2023-12-28 |
4 |
OE |
$12.74 |
$948,378 |
I/I |
74,441 |
2,675,421 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-03-05 |
4 |
AS |
$12.99 |
$129,875 |
D/D |
(10,000) |
270,039 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-03-04 |
4 |
AS |
$13.01 |
$130,108 |
D/D |
(10,000) |
280,039 |
0 |
% |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• • – |
2011-01-20 |
4 |
D |
$13.37 |
$68,347 |
D/D |
(5,112) |
671,057 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• • – |
2011-01-21 |
4 |
D |
$13.37 |
$17,127 |
D/D |
(1,281) |
669,776 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• • – |
2007-04-02 |
4 |
S |
$13.46 |
$2,720,111 |
D/D |
(202,090) |
189,486 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-05-20 |
4 |
AS |
$15.00 |
$18,316 |
D/D |
(1,221) |
177,853 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-05-19 |
4 |
AS |
$15.03 |
$765,917 |
D/D |
(50,965) |
179,074 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2023-12-08 |
4 |
AS |
$17.08 |
$137,784 |
D/D |
(8,067) |
101,320 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2023-12-11 |
4 |
AS |
$17.26 |
$1,189,027 |
D/D |
(68,870) |
32,450 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2023-12-12 |
4 |
AS |
$17.32 |
$711,026 |
D/D |
(41,063) |
0 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2023-12-28 |
4 |
D |
$19.65 |
$948,388 |
I/I |
(48,264) |
2,627,157 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2023-12-19 |
4 |
AS |
$20.01 |
$48,064 |
D/D |
(2,402) |
0 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2023-12-27 |
4 |
AS |
$20.04 |
$592,717 |
D/D |
(29,573) |
0 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2023-12-28 |
4 |
AS |
$20.04 |
$20,362 |
D/D |
(1,016) |
0 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2023-12-26 |
4 |
AS |
$20.22 |
$495,217 |
D/D |
(24,486) |
0 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2023-12-22 |
4 |
AS |
$20.43 |
$772,595 |
D/D |
(37,825) |
0 |
0 |
% |
|
140 Records found
|
|
Page 4 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
